Skip to main content

Why covid patients who could most benefit from paxlovid still aren’t getting it

During the pandemic, the federal government offered Americans a 5-day course of Paxlovid, the antiviral drug that lessens COVID-19 symptoms. But now that Pfizer is charging for it, confusion over insurance coverage, price, has made patients wary.

Paxlovid, Pfizer's anti-viral medication to treat the coronavirus disease (COVID-19), is displayed in this picture illustration taken Oct. 7, 2022. A morning and an evening dose consists of one white 100-milligram tablet of Ritonavir and two pink 150-milligram tablets of PF-07321332.

About That $1,390 List Price

Connecting With Patients

Texans need truth. Help us report it.

Support independent Texas news

Become a member. Join today.

Donate now

Explore related story topics

Health care